Two Sigma Advisers’s Vivani Medical VANI Stock Holding History

Two Sigma Advisers’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,600	Closed	-$44K	–	2816
2021 Q3	$44K	Buy	+4,600	New	+$51.8K	﹤0.01%	2379
2019 Q3	–	Sell	-446	Closed	-$9K	–	2402
2019 Q2	$9K	Sell	446 -142	-24%	-$2.91K	﹤0.01%	2287
2019 Q1	$11K	Sell	588 -33	-5%	-$643	﹤0.01%	2268
2018 Q4	$13K	Hold	621	–	–	﹤0.01%	2325
2018 Q3	$28K	Sell	621 -8	-1%	-$323	﹤0.01%	2196
2018 Q2	$25K	Buy	+629	New	+$27.4K	﹤0.01%	2322

Other funds holding VANI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Advisers's VANI Position: Q4 2021 in Review

Two Sigma Advisers sold out of Vivani Medical (VANI) in Q4 2021, closing a stake of 4,600 shares — an estimated $44K sold.

Two Sigma Advisers first reported a position in VANI in Q2 2018 and held it in 6 quarters. The position peaked at $44K in Q3 2021. 30 funds tracked by Wall St. Rank hold VANI as of Q4 2021.

Two Sigma Advisers reported no remaining Vivani Medical position as of Q4 2021 after selling out during the quarter.
Two Sigma Advisers sold 4,600 Vivani Medical shares in Q4 2021, an estimated $44K.
Two Sigma Advisers first reported a position in Vivani Medical in Q2 2018 and held it in 6 quarters.
Two Sigma Advisers's Vivani Medical position peaked at $44K in Q3 2021.
30 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2021.

Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.